Comparison of Bone Mineral Density Changes During Tx With Risperidone or Aripiprazole in Adolescents

Completed

Conditions studied: Psychiatry

In brief

This study examines if the use of antipsychotic medications might contribute to an interruption in bone mineral development and/or a reduction in bone mineral content in adolescents.

Key facts

Study ID

NCT00573716

Run by

Creighton University

People needed

60

Starts

2006-10-01

Expected to finish

2009-10-01

Last updated by the study team

2011-08-04

Who can join

Age: 11 and older, up to 17. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Between the ages of 11 and 17 years
• Females and males on aripiprazole or risperidone monotherapy for minimum one year
• Within 10th and 90th percentile for height and weight

You may not qualify if…

• Pregnancy
• Chronic illness such as asthma, inflammatory bowel disease, rheumatoid disorders or cystic fibrosis, on chronic systemic steroid therapy for past 12 months
• Menstrual irregularities secondary to excessive physical activity
• History of anorexia nervosa and/or bulimia nervosa
• Subjects on hormonal contraception

Where it is running

• Creighton Department of Psychiatry — Omaha, Nebraska, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.